Cogent Biosciences COGT
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 35.52 | 98.31 | -0.61 | -99,493 | -102 | |
| 2025Q3 | 14.36 | 104.89 | -0.50 | -83,355 | -81 | |
| 2025Q2 | 7.18 | 103.23 | -0.53 | -75,582 | -74 | |
| 2025Q1 | 5.99 | 104.09 | -0.52 | -74,933 | -72 | |
| 2024Q4 | 7.80 | 108.55 | -0.50 | -73,734 | -68 | |
| 2024Q3 | 10.80 | 106.77 | -0.53 | -75,414 | -71 | |
| 2024Q2 | 8.43 | 109.22 | -0.42 | -64,387 | -59 | |
| 2024Q1 | 6.72 | 106.95 | -0.49 | -62,404 | -58 | |
| 2023Q4 | 5.88 | 107.11 | -0.15 | -58,228 | -54 | |
| 2023Q3 | 9.75 | 107.58 | -0.65 | -59,580 | -55 | |
| 2023Q2 | 11.84 | 106.83 | -0.59 | -47,085 | -44 | |
| 2023Q1 | 10.79 | 112.05 | -0.55 | -43,237 | -39 | |
| 2022Q4 | 11.56 | 110.42 | 0.11 | -43,745 | -40 | |
| 2022Q3 | 14.92 | 105.02 | -0.45 | -36,821 | -35 | |
| 2022Q2 | 9.02 | 102.66 | -0.71 | -35,855 | -35 | |
| 2022Q1 | 7.49 | 102.56 | -0.68 | -31,418 | -31 | |
| 2021Q4 | 8.58 | 102.92 | -0.62 | -25,640 | -25 | |
| 2021Q3 | 8.41 | 103.85 | -0.48 | -19,819 | -19 | |
| 2021Q2 | 8.11 | 104.49 | -0.43 | -17,292 | -17 | |
| 2021Q1 | 8.78 | 109.14 | -0.34 | -12,800 | -12 |